Long-term antibody-response monitoring following primary exposure to SARS-COV-2 and afterward mRNA COVID-19 vaccination: A case report

nema

Saved in:
Bibliographic Details
Main Authors: Balint Bela, Todorović Milena, Andrić Zorana, Jovičić Milica, Blagojević Glorija, Čolić Miodrag
Format: Article
Language:English
Published: Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade 2021-01-01
Series:Vojnosanitetski Pregled
Subjects:
Online Access:http://www.doiserbia.nb.rs/img/doi/0042-8450/2021/0042-84502100019B.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849305158723305472
author Balint Bela
Todorović Milena
Andrić Zorana
Jovičić Milica
Blagojević Glorija
Čolić Miodrag
author_facet Balint Bela
Todorović Milena
Andrić Zorana
Jovičić Milica
Blagojević Glorija
Čolić Miodrag
author_sort Balint Bela
collection DOAJ
description nema
format Article
id doaj-art-037a810b9b31415d8ba113db7271e486
institution Kabale University
issn 0042-8450
2406-0720
language English
publishDate 2021-01-01
publisher Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade
record_format Article
series Vojnosanitetski Pregled
spelling doaj-art-037a810b9b31415d8ba113db7271e4862025-08-20T03:55:32ZengMinistry of Defence of the Republic of Serbia, University of Defence, BelgradeVojnosanitetski Pregled0042-84502406-07202021-01-0178337938110.2298/VSP200220019B0042-84502100019BLong-term antibody-response monitoring following primary exposure to SARS-COV-2 and afterward mRNA COVID-19 vaccination: A case reportBalint Bela0https://orcid.org/0000-0001-5392-1071Todorović Milena1Andrić Zorana2Jovičić Milica3Blagojević Glorija4Čolić Miodrag5https://orcid.org/0000-0002-6602-9493Serbian Academy of Sciences and Arts, Department of Medical Sciences, Belgrade, Serbia + Institute of Cardiovascular Diseases Dedinje”, †Department of Transfusion Medicine, Belgrade, SerbiaUniversity Clinical Center of Serbia, Clinic for Hematology, Belgrade, Serbia + University of Belgrade, Faculty of Medicine, Belgrade, SerbiaBlood Transfusion Institute of Serbia, Belgrade, SerbiaBlood Transfusion Institute of Serbia, Belgrade, SerbiaBlood Transfusion Institute of Serbia, Belgrade, SerbiaSerbian Academy of Sciences and Arts, Department of Medical Sciences, Belgrade, Serbianemahttp://www.doiserbia.nb.rs/img/doi/0042-8450/2021/0042-84502100019B.pdfantibodiescovid-19covid-19 serotherapyinfectionsvaccination
spellingShingle Balint Bela
Todorović Milena
Andrić Zorana
Jovičić Milica
Blagojević Glorija
Čolić Miodrag
Long-term antibody-response monitoring following primary exposure to SARS-COV-2 and afterward mRNA COVID-19 vaccination: A case report
Vojnosanitetski Pregled
antibodies
covid-19
covid-19 serotherapy
infections
vaccination
title Long-term antibody-response monitoring following primary exposure to SARS-COV-2 and afterward mRNA COVID-19 vaccination: A case report
title_full Long-term antibody-response monitoring following primary exposure to SARS-COV-2 and afterward mRNA COVID-19 vaccination: A case report
title_fullStr Long-term antibody-response monitoring following primary exposure to SARS-COV-2 and afterward mRNA COVID-19 vaccination: A case report
title_full_unstemmed Long-term antibody-response monitoring following primary exposure to SARS-COV-2 and afterward mRNA COVID-19 vaccination: A case report
title_short Long-term antibody-response monitoring following primary exposure to SARS-COV-2 and afterward mRNA COVID-19 vaccination: A case report
title_sort long term antibody response monitoring following primary exposure to sars cov 2 and afterward mrna covid 19 vaccination a case report
topic antibodies
covid-19
covid-19 serotherapy
infections
vaccination
url http://www.doiserbia.nb.rs/img/doi/0042-8450/2021/0042-84502100019B.pdf
work_keys_str_mv AT balintbela longtermantibodyresponsemonitoringfollowingprimaryexposuretosarscov2andafterwardmrnacovid19vaccinationacasereport
AT todorovicmilena longtermantibodyresponsemonitoringfollowingprimaryexposuretosarscov2andafterwardmrnacovid19vaccinationacasereport
AT andriczorana longtermantibodyresponsemonitoringfollowingprimaryexposuretosarscov2andafterwardmrnacovid19vaccinationacasereport
AT jovicicmilica longtermantibodyresponsemonitoringfollowingprimaryexposuretosarscov2andafterwardmrnacovid19vaccinationacasereport
AT blagojevicglorija longtermantibodyresponsemonitoringfollowingprimaryexposuretosarscov2andafterwardmrnacovid19vaccinationacasereport
AT colicmiodrag longtermantibodyresponsemonitoringfollowingprimaryexposuretosarscov2andafterwardmrnacovid19vaccinationacasereport